Management of lymphoma survivor patients in Italy: an evaluation by Fondazione Italiana Linfomi.


Journal

Tumori
ISSN: 2038-2529
Titre abrégé: Tumori
Pays: United States
ID NLM: 0111356

Informations de publication

Date de publication:
Feb 2021
Historique:
pubmed: 3 3 2020
medline: 20 2 2021
entrez: 3 3 2020
Statut: ppublish

Résumé

Several outpatient models for the follow-up of cancer survivors have been developed worldwide. A multidisciplinary approach is often necessary to guarantee the best monitoring of long-term toxicities. Guidelines also indicate a close education on healthy lifestyles. In this context, we have analyzed the Italian follow-up modalities of lymphoma survivors, with the aim to have a starting line to hypothesize and plan the best model for Italian hematology centers.

Identifiants

pubmed: 32116159
doi: 10.1177/0300891620905649
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

91-94

Auteurs

Carla Minoia (C)

Haematology Unit, IRCCS Istituto Tumori "Giovanni Paolo II," Bari, Italy.

Alessia Bari (A)

Department of Oncology and Hematology, Modena Cancer Center Unit of Target Therapy in Onco-Hematology and Osteoncology, University of Modena and Reggio Emilia Modena, Modena, Italy.

Luca Nassi (L)

Division of Hematology, Department of Translational Medicine, Azienda Ospedaliero Universitaria Maggiore della Carità Novara, Italy.

Rita Banzi (R)

Mario Negri Institute for Pharmacological Research, IRCCS Milan, Milano, Lombardia, Italy.

Chiara Gerardi (C)

Mario Negri Institute for Pharmacological Research, IRCCS Milan, Milano, Lombardia, Italy.

Valentina Lenti (V)

Fondazione Italiana Linfomi, Alessandria, Italy.

Marco Calabrese (M)

Fondazione Italiana Linfomi, Alessandria, Italy.

Michele Spina (M)

Division of Medical Oncology, Centro di Riferimento Oncologico, Aviano National Cancer Institute Aviano, Aviano, Friuli-Venezia Giulia, Italy.

Attilio Guarini (A)

Haematology Unit, IRCCS Istituto Tumori "Giovanni Paolo II," Bari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH